Literature DB >> 10471621

Clara cell protein-positive epithelial cells are reduced in small airways of asthmatics.

N Shijubo1, Y Itoh, T Yamaguchi, A Imada, M Hirasawa, T Yamada, T Kawai, S Abe.   

Abstract

Clara cell 10 kilodalton protein (CC10), the predominant product from nonciliated cells in the epithelial lining of bronchioles (Clara cells), has been shown to have immunomodulatory and anti-inflammatory activity, and may play roles in controlling inflammation in the airway. This study was designed to examine immunohistochemical expression of CC10 in epithelial cells in small airways (perimeter < 6 mm) of asthmatic and control nonsmokers who underwent lung resection because of peripheral lung carcinoma and to compare CC10-positive epithelial cell proportions with numbers of inflammatory cells in small airways of asthmatics. Significantly decreased proportions of CC10-positive epithelial cells and significantly increased numbers of T cells, activated eosinophils, and mast cells in small airways of asthmatics were found compared with those of control subjects. CC10-positive epithelial cell proportions inversely correlated with numbers of T cells and mast cells in small airways of asthmatics. Decreases of CC10-producing cells may give an accelerating cause for further aggravation of inflammatory responses in chronic asthma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471621     DOI: 10.1164/ajrccm.160.3.9803113

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  36 in total

1.  Restoration of the normal Clara cell phenotype after chronic allergic inflammation.

Authors:  Felix D Roth; Amado A Quintar; Carolina Leimgruber; Luciana García; Elisa M Uribe Echevarría; Alicia I Torres; Cristina A Maldonado
Journal:  Int J Exp Pathol       Date:  2013-09-02       Impact factor: 1.925

Review 2.  Small airways disease in asthma.

Authors:  Jonathan Corren
Journal:  Curr Allergy Asthma Rep       Date:  2008-11       Impact factor: 4.806

3.  Maintenance and repair of the bronchiolar epithelium.

Authors:  Barry R Stripp; Susan D Reynolds
Journal:  Proc Am Thorac Soc       Date:  2008-04-15

4.  A polymorphism in the human UGRP1 gene promoter that regulates transcription is associated with an increased risk of asthma.

Authors:  Tomoaki Niimi; Mitsuru Munakata; Catherine L Keck-Waggoner; Nicholas C Popescu; Roy C Levitt; Michie Hisada; Shioko Kimura
Journal:  Am J Hum Genet       Date:  2002-01-25       Impact factor: 11.025

5.  The Club Cell Marker SCGB1A1 Downstream of FOXA2 is Reduced in Asthma.

Authors:  Lingxiang Zhu; Lingling An; Di Ran; Rosa Lizarraga; Cheryl Bondy; Xu Zhou; Richart W Harper; Shu-Yi Liao; Yin Chen
Journal:  Am J Respir Cell Mol Biol       Date:  2019-06       Impact factor: 6.914

Review 6.  Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease: a critical review of the literature.

Authors:  Ho Il Yoon; Don D Sin
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

Review 7.  Ion channels of the lung and their role in disease pathogenesis.

Authors:  Rafal Bartoszewski; Sadis Matalon; James F Collawn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-12       Impact factor: 5.464

8.  Aryl hydrocarbon receptor promotes lipid droplet biogenesis and metabolic shift in respiratory Club cells.

Authors:  Hsueh-Chun Wang; Kwei-Yan Liu; Li-Ting Wang; Shih-Hsien Hsu; Shao-Chun Wang; Shau-Ku Huang
Journal:  Hum Cell       Date:  2021-03-08       Impact factor: 4.174

9.  In vivo Cre/loxP mediated recombination in mouse Clara cells.

Authors:  Guillaume Bertin; Chantal Poujeol; Isabelle Rubera; Philippe Poujeol; Michel Tauc
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

10.  Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study.

Authors:  Rogier M Determann; Julian L Millo; Sam Waddy; Rene Lutter; Chris S Garrard; Marcus J Schultz
Journal:  BMC Pulm Med       Date:  2009-12-03       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.